Thatcher N - Search Results

1

A phase I study of a 24 hour infusion of gemcitabine in previously untreated patients with inoperable non-small-cell lung cancer.

Anderson H, Thatcher N, Walling J, Hansen H. Anderson H, et al. Among authors: thatcher n. Br J Cancer. 1996 Aug;74(3):460-2. doi: 10.1038/bjc.1996.382. Br J Cancer. 1996. PMID: 8695365 Free PMC article. Clinical Trial.

2

Sequential platinum-based chemotherapy-thoracic radiotherapy in early stage non-small cell lung cancer.

Thatcher N, Faivre-Finn C, Blackhall F, Anderson H, Lorigan P. Thatcher N, et al. Clin Cancer Res. 2005 Jul 1;11(13 Pt 2):5051s-5056s. doi: 10.1158/1078-0432.CCR-05-9004. Clin Cancer Res. 2005. PMID: 16000613 Free article. Review.

3

Phase III trial of gemcitabine and carboplatin versus mitomycin, ifosfamide, and cisplatin or mitomycin, vinblastine, and cisplatin in patients with advanced nonsmall cell lung carcinoma.

Danson S, Middleton MR, O'Byrne KJ, Clemons M, Ranson M, Hassan J, Anderson H, Burt PA, Fairve-Finn C, Stout R, Dowd I, Ashcroft L, Beresford C, Thatcher N. Danson S, et al. Among authors: thatcher n. Cancer. 2003 Aug 1;98(3):542-53. doi: 10.1002/cncr.11535. Cancer. 2003. PMID: 12879472 Free article. Clinical Trial.

4

Predicting septic complications of chemotherapy: an analysis of 382 patients treated for small cell lung cancer without dose reduction after major sepsis.

Radford JA, Ryder WD, Dodwell D, Anderson H, Thatcher N. Radford JA, et al. Among authors: thatcher n. Eur J Cancer. 1992;29A(1):81-6. doi: 10.1016/0959-8049(93)90581-y. Eur J Cancer. 1992. PMID: 1332739

5

Recombinant human GM-CSF in small cell lung cancer: a phase I/II study.

Anderson H, Gurney H, Thatcher N, Swindell R, Scarffe JH, Weiner J. Anderson H, et al. Among authors: thatcher n. Recent Results Cancer Res. 1991;121:155-61. doi: 10.1007/978-3-642-84138-5_17. Recent Results Cancer Res. 1991. PMID: 1650015 Clinical Trial.

6

Phase II study with mitomycin, ifosfamide and carboplatin in inoperable non-small cell lung cancer.

von Rohr A, Anderson H, McIntosh R, Thatcher N. von Rohr A, et al. Among authors: thatcher n. Eur J Cancer. 1991;27(9):1106-8. doi: 10.1016/0277-5379(91)90303-u. Eur J Cancer. 1991. PMID: 1659850

7

A randomised study of intravenous bolus versus continuous infusion of ifosfamide and doxorubicin with oral etoposide for small-cell lung cancer.

Anderson H, Prendiville J, Thatcher N, Radford JA, Swindell R. Anderson H, et al. Among authors: thatcher n. J Cancer Res Clin Oncol. 1991;117 Suppl 4:S139-40. doi: 10.1007/BF01613219. J Cancer Res Clin Oncol. 1991. PMID: 1665490 Clinical Trial.

8

Therapy for poor-risk patients with small-cell lung cancer using bolus ifosfamide and oral etoposide.

Anderson H, Lind MJ, Thatcher N, Swindell R, Woodcock A, Carroll KB. Anderson H, et al. Among authors: thatcher n. Cancer Chemother Pharmacol. 1990;26(1):71-4. doi: 10.1007/BF02940299. Cancer Chemother Pharmacol. 1990. PMID: 2157555

9

Ifosfamide, etoposide, and thoracic irradiation therapy in 163 patients with unresectable small cell lung cancer.

Thatcher N, Cerny T, Stout R, Anderson H, Barber PV, Wolstenholme RJ, Barnes P, Deiraniya A. Thatcher N, et al. Cancer. 1987 Nov 15;60(10):2382-7. doi: 10.1002/1097-0142(19871115)60:10<2382::aid-cncr2820601006>3.0.co;2-v. Cancer. 1987. PMID: 2822217

10

24-hour cyclophosphamide infusion therapy for malignant mesothelioma of the pleura.

Anderson H, Hasleton P, Michie AB, Johnson RJ, Thatcher N. Anderson H, et al. Among authors: thatcher n. Br J Dis Chest. 1988 Jan;82(1):64-9. doi: 10.1016/0007-0971(88)90009-5. Br J Dis Chest. 1988. PMID: 3166920

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

391 results

Search Page

Filters